Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 02:07PM ET
1.66
Dollar change
+0.16
Percentage change
10.98
%
IndexRUT P/E- EPS (ttm)-1.14 Insider Own3.03% Shs Outstand267.74M Perf Week27.08%
Market Cap453.40M Forward P/E- EPS next Y-0.72 Insider Trans-1.88% Shs Float264.11M Perf Month-8.53%
Income-296.90M PEG- EPS next Q-0.23 Inst Own92.53% Short Float21.38% Perf Quarter-50.75%
Sales200.43M P/S2.26 EPS this Y23.97% Inst Trans-6.30% Short Ratio5.15 Perf Half Y-79.09%
Book/sh2.38 P/B0.70 EPS next Y21.62% ROA-16.65% Short Interest56.47M Perf Year-87.95%
Cash/sh2.06 P/C0.81 EPS next 5Y-1.00% ROE-44.28% 52W Range1.16 - 14.55 Perf YTD-83.03%
Dividend Est.- P/FCF- EPS past 5Y-9.76% ROI-18.90% 52W High-88.56% Beta2.05
Dividend TTM- Quick Ratio8.36 Sales past 5Y24.48% Gross Margin17.49% 52W Low43.51% ATR (14)0.15
Dividend Ex-Date- Current Ratio9.28 EPS Y/Y TTM18.48% Oper. Margin-156.06% RSI (14)55.60 Volatility8.08% 8.62%
Employees796 Debt/Eq1.44 Sales Y/Y TTM49.54% Profit Margin-148.13% Recom2.13 Target Price3.33
Option/ShortYes / Yes LT Debt/Eq1.42 EPS Q/Q20.24% Payout- Rel Volume1.02 Prev Close1.50
Sales Surprise-10.66% EPS Surprise-5.26% Sales Q/Q-0.23% EarningsMay 09 AMC Avg Volume10.96M Price1.66
SMA2013.17% SMA50-3.45% SMA200-68.35% Trades Volume8,138,192 Change10.98%
Date Action Analyst Rating Change Price Target Change
Jun-03-24Resumed Jefferies Buy $4
Apr-22-24Downgrade JP Morgan Overweight → Neutral
Apr-18-24Downgrade Goldman Buy → Neutral $7 → $2.50
Dec-14-23Initiated Stephens Overweight $11
Dec-14-23Initiated Guggenheim Neutral
Dec-13-23Initiated Wolfe Research Peer Perform
Nov-17-23Upgrade UBS Neutral → Buy $13 → $10
Oct-31-23Upgrade Cantor Fitzgerald Neutral → Overweight $11
Sep-28-23Initiated Bernstein Outperform $11
Jul-05-23Resumed JP Morgan Overweight $13
Jul-02-24 11:56AM
Jul-01-24 10:26AM
Jun-28-24 06:15PM
Jun-27-24 10:09AM
09:00AM
04:36PM Loading…
Jun-26-24 04:36PM
Jun-18-24 06:15PM
Jun-13-24 10:12AM
Jun-10-24 09:05AM
May-29-24 01:00PM
May-27-24 08:00AM
May-23-24 09:00AM
May-15-24 11:53AM
10:48AM
09:45AM
03:46AM Loading…
May-14-24 03:46AM
May-13-24 09:47AM
May-10-24 06:32PM
02:43PM
11:16AM
May-09-24 08:55PM
06:30PM
06:10PM
05:04PM
04:05PM
May-07-24 12:12PM
May-02-24 09:00AM
Apr-25-24 09:35AM
Apr-23-24 12:00PM
Apr-17-24 01:00PM
02:47PM Loading…
Apr-16-24 02:47PM
08:05AM
Apr-03-24 10:54AM
Mar-27-24 08:00AM
Mar-22-24 04:30PM
Mar-13-24 03:32PM
10:17AM
Mar-12-24 09:05AM
Mar-06-24 11:57PM
Feb-27-24 03:30AM
Feb-26-24 04:05PM
Feb-25-24 07:04AM
Feb-22-24 04:21AM
Feb-16-24 10:50AM
08:59AM
08:34AM
Feb-15-24 06:30PM
05:30PM
04:43PM
04:28PM
04:05PM
Feb-13-24 07:00AM
Feb-10-24 05:09PM
Feb-06-24 09:41AM
Feb-05-24 09:05AM
Jan-25-24 04:03PM
Jan-16-24 12:13PM
Jan-15-24 09:05AM
Jan-11-24 10:00AM
Jan-09-24 10:43AM
Jan-08-24 08:00AM
Dec-27-23 04:05PM
Dec-26-23 08:24AM
Dec-20-23 01:50PM
Dec-11-23 08:00AM
Dec-10-23 04:00PM
11:59AM
Nov-10-23 09:30AM
Nov-09-23 04:10PM
Nov-02-23 09:05AM
Nov-01-23 09:05AM
Oct-31-23 11:35AM
09:34AM
09:05AM
Oct-30-23 06:00PM
04:19PM
04:03PM
03:46PM
Oct-18-23 05:52AM
Oct-17-23 10:04AM
Oct-16-23 10:43AM
08:05AM
Oct-12-23 04:03PM
Oct-11-23 09:05AM
Oct-06-23 12:11PM
Sep-19-23 12:07PM
Sep-18-23 11:55AM
Sep-14-23 12:56PM
12:32PM
07:30AM
Sep-13-23 12:48PM
Sep-12-23 08:00AM
Sep-08-23 07:23AM
Sep-07-23 09:05AM
Sep-05-23 12:25PM
09:52AM
Aug-09-23 04:03PM
10:00AM
08:16AM
Aug-07-23 09:18AM
Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farmer MicheleSee RemarksMay 20 '24Sale2.035,27510,708211,941May 22 05:25 PM
ORDONEZ KATHYDirectorMar 15 '24Option Exercise2.87361,6211,038,682380,216Mar 19 04:24 PM
Meline David WDirectorMar 06 '24Buy4.4040,000176,16040,000Mar 06 05:36 PM
HENRY CHRISTIAN OSee RemarksMar 04 '24Sale4.8714,17769,0562,596,670Mar 06 05:12 PM
Van Oene MarkSee RemarksMar 04 '24Sale4.879,18644,7451,668,826Mar 06 05:26 PM
Kim Susan G.See RemarksMar 04 '24Sale4.875,27525,695712,260Mar 06 05:22 PM
Farmer MicheleSee RemarksMar 04 '24Sale4.872,96814,457217,216Mar 06 05:30 PM
MOHR MARSHALLDirectorMar 01 '24Option Exercise4.4525,000111,250110,000Mar 05 04:27 PM
HENRY CHRISTIAN OSee RemarksFeb 20 '24Sale5.261,97910,4121,005,078Feb 21 06:14 PM
Kim Susan G.See RemarksFeb 20 '24Sale5.268314,372282,758Feb 21 06:17 PM
HENRY CHRISTIAN OSee RemarksFeb 16 '24Sale5.9679,038470,9081,007,057Feb 21 06:14 PM
Van Oene MarkSee RemarksFeb 16 '24Sale5.9633,560199,950876,611Feb 21 06:25 PM
Kim Susan G.See RemarksFeb 16 '24Sale5.9622,496134,031283,589Feb 21 06:17 PM
Eidel JeffSee RemarksFeb 16 '24Sale5.9615,49892,337431,824Feb 21 06:20 PM
Farmer MicheleSee RemarksFeb 16 '24Sale5.967,56245,054101,164Feb 21 06:07 PM
Van Oene MarkSee RemarksJan 09 '24Sale7.7731,012241,056910,171Jan 10 05:44 PM
HENRY CHRISTIAN OSee RemarksDec 14 '23Sale10.0020,000200,0001,086,095Dec 15 04:35 PM
Kim Susan G.See RemarksSep 29 '23Sale8.4419,257162,471306,085Sep 29 06:47 PM
HENRY CHRISTIAN OSee RemarksSep 18 '23Sale10.1296,844980,2551,106,095Sep 19 04:32 PM
HENRY CHRISTIAN OSee RemarksSep 11 '23Sale10.4510,000104,5201,202,939Sep 12 04:42 PM
Eidel JeffSee RemarksAug 17 '23Sale10.6025,936274,844444,666Aug 18 04:36 PM
HENRY CHRISTIAN OSee RemarksAug 17 '23Sale10.5010,000105,0001,212,939Aug 18 04:44 PM
Van Oene MarkSee RemarksAug 16 '23Sale11.0026,102287,122939,769Aug 18 04:26 PM
Last Close
Jul 12 02:07PM ET
122.23
Dollar change
-0.59
Percentage change
-0.48
%
MRNA Moderna Inc daily Stock Chart
IndexNDX, S&P 500 P/E- EPS (ttm)-15.68 Insider Own12.14% Shs Outstand382.00M Perf Week3.31%
Market Cap46.84B Forward P/E- EPS next Y-5.32 Insider Trans-1.25% Shs Float336.72M Perf Month-17.63%
Income-5968.00M PEG- EPS next Q-3.35 Inst Own67.25% Short Float6.57% Perf Quarter14.22%
Sales5.14B P/S9.10 EPS this Y42.78% Inst Trans0.89% Short Ratio5.65 Perf Half Y11.67%
Book/sh33.46 P/B3.65 EPS next Y24.63% ROA-29.22% Short Interest22.13M Perf Year-2.93%
Cash/sh22.28 P/C5.49 EPS next 5Y- ROE-37.68% 52W Range62.55 - 170.47 Perf YTD22.91%
Dividend Est.- P/FCF- EPS past 5Y-20.02% ROI-42.54% 52W High-28.30% Beta1.66
Dividend TTM- Quick Ratio3.91 Sales past 5Y662.08% Gross Margin11.10% 52W Low95.41% ATR (14)6.22
Dividend Ex-Date- Current Ratio4.03 EPS Y/Y TTM-227.99% Oper. Margin-100.04% RSI (14)43.26 Volatility3.48% 4.26%
Employees5600 Debt/Eq0.10 Sales Y/Y TTM-65.53% Profit Margin-116.00% Recom2.44 Target Price144.32
Option/ShortYes / Yes LT Debt/Eq0.09 EPS Q/Q-1676.58% Payout- Rel Volume1.07 Prev Close122.82
Sales Surprise79.07% EPS Surprise13.68% Sales Q/Q-91.07% EarningsMay 02 BMO Avg Volume3.91M Price122.23
SMA20-4.09% SMA50-8.78% SMA20017.20% Trades Volume3,028,935 Change-0.48%
Date Action Analyst Rating Change Price Target Change
Feb-26-24Downgrade HSBC Securities Hold → Reduce $75 → $86
Jan-02-24Upgrade Oppenheimer Perform → Outperform $142
Nov-29-23Initiated Canaccord Genuity Hold $82
Nov-03-23Upgrade HSBC Securities Reduce → Hold $89 → $69
Nov-02-23Downgrade Deutsche Bank Hold → Sell $125 → $60
Aug-04-23Downgrade TD Cowen Outperform → Market Perform $145 → $125
Aug-03-23Downgrade Deutsche Bank Buy → Hold $125
Jul-24-23Initiated William Blair Mkt Perform $136.28
Jul-14-23Initiated HSBC Securities Reduce $97
Jun-26-23Upgrade UBS Neutral → Buy $221 → $191
Jul-10-24 02:34PM
02:06PM
08:50AM
07:00AM
06:00AM
06:00AM Loading…
06:00AM
Jul-09-24 05:50PM
04:12AM
Jul-08-24 07:00PM
04:45PM
09:00AM
Jul-05-24 07:30AM
06:55AM
Jul-03-24 12:49PM
10:18AM
10:03AM Loading…
10:03AM
07:08AM
07:00AM
04:52AM
01:41AM
Jul-02-24 01:38PM
01:33PM
10:34AM
10:29AM
10:18AM
10:03AM
09:59AM
08:43AM
08:04AM
07:30AM
11:00PM Loading…
Jul-01-24 11:00PM
10:52AM
10:24AM
07:19AM
Jun-28-24 10:28AM
07:00AM
Jun-27-24 11:10AM
11:10AM
08:30AM
07:30AM
04:27AM
Jun-26-24 05:58PM
05:05PM
04:13PM
04:12PM
03:57PM
03:22PM
02:28PM
12:54PM
12:21PM
11:57AM
Jun-25-24 05:50PM
01:01AM
Jun-24-24 12:02PM
Jun-20-24 01:32PM
Jun-18-24 10:19AM
Jun-17-24 05:50PM
04:33PM
Jun-16-24 09:45AM
Jun-15-24 01:54AM
Jun-14-24 05:00AM
04:32AM
Jun-13-24 07:07AM
07:00AM
Jun-12-24 12:30PM
11:53AM
07:00AM
Jun-11-24 11:53AM
10:10AM
06:00AM
Jun-10-24 05:50PM
04:05PM
01:27PM
10:53AM
10:38AM
09:40AM
08:26AM
08:24AM
07:32AM
06:30AM
06:30AM
05:50AM
Jun-08-24 06:45AM
Jun-07-24 12:05PM
10:30AM
05:00AM
Jun-06-24 04:37PM
11:38AM
10:05AM
09:28AM
07:47AM
07:00AM
06:26AM
Jun-05-24 05:37PM
05:02PM
Jun-04-24 01:45PM
06:00AM
04:25AM
Jun-03-24 04:30PM
04:17PM
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mock James MChief Financial OfficerJul 08 '24Sale118.2468981,4657,269Jul 09 04:34 PM
AFEYAN NOUBARDirectorJun 26 '24Sale127.2215,0001,908,2932,284,015Jun 28 07:00 PM
AFEYAN NOUBARDirectorJun 18 '24Sale133.5715,0002,003,5612,299,015Jun 21 07:00 PM
Hoge StephenPresidentJun 17 '24Sale138.1615,0002,072,4001,457,089Jun 18 04:05 PM
AFEYAN NOUBARDirectorJun 12 '24Sale147.2015,0002,208,0712,314,015Jun 14 07:00 PM
AFEYAN NOUBARDirectorJun 11 '24Sale148.34202,83230,087,3391,528,557Jun 11 07:01 PM
Klinger Shannon ThymeChief Legal OfficerJun 10 '24Sale148.095,178766,78515,947Jun 11 04:05 PM
AFEYAN NOUBARDirectorJun 05 '24Sale151.2515,0002,268,8041,946,931Jun 07 07:00 PM
Mock James MChief Financial OfficerJun 03 '24Sale140.7269197,2376,506Jun 04 05:27 PM
Hoge StephenPresidentJun 03 '24Sale140.7233947,7041,472,089Jun 04 05:20 PM
Klinger Shannon ThymeChief Legal OfficerJun 03 '24Sale140.7212217,16810,878Jun 04 05:12 PM
AFEYAN NOUBARDirectorMay 29 '24Sale145.0820,0002,901,5851,961,931May 31 07:00 PM
Hoge StephenPresidentMay 29 '24Sale144.5034149,2761,471,777May 30 04:14 PM
Mock James MChief Financial OfficerMay 29 '24Sale144.5018326,4445,871May 30 04:36 PM
Klinger Shannon ThymeChief Legal OfficerMay 29 '24Sale144.5018326,44410,768May 30 04:27 PM
Klinger Shannon ThymeChief Legal OfficerMay 28 '24Sale162.471,296210,56610,623May 29 04:12 PM
Mock James MChief Financial OfficerMay 28 '24Sale162.47648105,2835,726May 29 04:16 PM
AFEYAN NOUBARDirectorMay 22 '24Sale157.5715,0002,363,5561,981,931May 24 07:00 PM
Hoge StephenPresidentMay 15 '24Sale127.4915,0001,912,3501,471,508May 17 04:04 PM
AFEYAN NOUBARDirectorMay 15 '24Sale127.3215,0001,909,8631,996,931May 17 07:00 PM
Hoge StephenPresidentMay 10 '24Sale120.9625530,8441,486,508May 13 04:03 PM
AFEYAN NOUBARDirectorMay 08 '24Sale121.6815,0001,825,2202,011,931May 10 07:00 PM
AFEYAN NOUBARDirectorMay 01 '24Sale110.9215,0001,663,8552,026,931May 03 07:00 PM
AFEYAN NOUBARDirectorApr 24 '24Sale108.3215,0001,624,8362,041,931Apr 26 07:00 PM
AFEYAN NOUBARDirectorApr 17 '24Sale103.3815,0001,550,7032,056,931Apr 19 07:00 PM
Hoge StephenPresidentApr 15 '24Sale105.0215,0001,575,3001,486,241Apr 16 04:23 PM
AFEYAN NOUBARDirectorApr 10 '24Sale107.1215,0001,606,8652,071,931Apr 12 07:00 PM
Mock James MChief Financial OfficerApr 08 '24Sale101.9370571,8595,048Apr 09 04:09 PM
AFEYAN NOUBARDirectorApr 03 '24Sale101.6815,0001,525,2682,086,931Apr 05 07:00 PM
AFEYAN NOUBARDirectorMar 27 '24Sale109.0615,0001,635,8642,101,931Mar 29 07:00 PM
AFEYAN NOUBARDirectorMar 20 '24Sale102.3915,0001,535,8202,116,931Mar 22 07:00 PM
Hoge StephenPresidentMar 15 '24Sale103.1715,0001,547,5501,501,241Mar 19 04:39 PM
AFEYAN NOUBARDirectorMar 13 '24Sale108.5415,0001,628,0312,131,931Mar 15 07:00 PM
Klinger Shannon ThymeChief Legal OfficerMar 08 '24Sale99.0554453,8849,267Mar 11 09:05 AM
Hoge StephenPresidentMar 04 '24Sale94.3430929,1511,516,241Mar 05 05:52 PM
Klinger Shannon ThymeChief Legal OfficerMar 04 '24Sale94.3411711,0388,673Mar 05 05:56 PM
Hoge StephenPresidentFeb 29 '24Sale94.572,388225,8381,515,898Mar 01 05:25 PM
Klinger Shannon ThymeChief Legal OfficerFeb 29 '24Sale94.5767063,3638,557Mar 01 05:29 PM
Mock James MChief Financial OfficerFeb 29 '24Sale94.5764761,1884,300Mar 01 05:33 PM
Hoge StephenPresidentFeb 22 '24Sale100.0015,0001,500,0001,513,433Feb 23 04:04 PM
Bancel StephaneChief Executive OfficerFeb 16 '24Sale88.8826,3512,342,0985,460,224Feb 16 04:10 PM
Hoge StephenPresidentFeb 16 '24Sale88.8810,542936,9811,528,433Feb 16 04:19 PM
Hoge StephenPresidentFeb 12 '24Sale86.2330426,2141,516,281Feb 13 04:13 PM
Hoge StephenPresidentJan 16 '24Sale103.9015,0001,558,5001,516,063Jan 17 04:12 PM
Mock James MChief Financial OfficerJan 08 '24Sale109.7577284,7313,632Jan 09 04:08 PM
Hoge StephenPresidentDec 27 '23Sale100.0145,0004,500,4501,531,063Dec 28 08:00 AM
Klinger Shannon ThymeChief Legal OfficerDec 08 '23Sale79.0956344,5257,912Dec 11 04:03 PM
Garay ArpaChief Commercial OfficerDec 06 '23Sale78.3456444,1823,690Dec 07 04:21 PM
Hoge StephenPresidentDec 04 '23Sale79.3130924,5081,576,063Dec 05 04:07 PM
Klinger Shannon ThymeChief Legal OfficerDec 04 '23Sale79.311118,8047,336Dec 05 04:10 PM
Hoge StephenPresidentNov 29 '23Sale79.811,13690,6661,575,721Nov 30 04:11 PM
Hoge StephenPresidentNov 10 '23Sale68.7626318,0841,574,446Nov 13 04:02 PM
AFEYAN NOUBARDirectorNov 01 '23Sale76.0010,000760,0322,146,931Nov 03 07:00 PM
AFEYAN NOUBARDirectorOct 25 '23Sale76.9910,000769,8542,156,931Oct 27 07:00 PM
AFEYAN NOUBARDirectorOct 11 '23Sale103.3015,0001,549,4412,166,931Oct 13 07:00 PM
Mock James MChief Financial OfficerOct 06 '23Sale102.502,858292,9532,952Oct 10 04:51 PM
AFEYAN NOUBARDirectorOct 04 '23Sale102.7215,0001,540,8452,181,931Oct 06 07:02 PM
AFEYAN NOUBARDirectorSep 27 '23Sale98.9610,000989,6462,196,931Sep 29 07:00 PM
AFEYAN NOUBARDirectorSep 20 '23Sale104.7415,0001,571,0902,206,931Sep 22 07:00 PM
Hoge StephenPresidentSep 15 '23Sale112.9915,0001,694,8501,574,187Sep 18 04:06 PM
AFEYAN NOUBARDirectorSep 13 '23Sale109.7015,0001,645,5222,221,931Sep 15 07:00 PM
Klinger Shannon ThymeChief Legal OfficerSep 08 '23Sale107.2255759,7227,215Sep 11 04:02 PM
AFEYAN NOUBARDirectorSep 06 '23Sale107.6115,0001,614,0941,982,209Sep 08 07:01 PM
Garay ArpaChief Commercial OfficerSep 06 '23Sale108.4057462,2193,113Sep 07 04:46 PM
Hoge StephenPresidentSep 05 '23Sale111.4432035,6601,589,187Sep 06 04:08 PM
Klinger Shannon ThymeChief Legal OfficerSep 05 '23Sale111.4411512,8156,634Sep 06 04:17 PM
AFEYAN NOUBARDirectorAug 30 '23Sale115.4615,0001,731,9511,997,209Sep 01 07:00 PM
Hoge StephenPresidentAug 29 '23Sale115.011,135130,5421,588,855Aug 30 04:07 PM
AFEYAN NOUBARDirectorAug 23 '23Sale115.5115,0001,732,6132,012,209Aug 25 07:00 PM
Hoge StephenPresidentAug 17 '23Sale100.0015,0001,500,0001,587,579Aug 18 05:16 PM
AFEYAN NOUBARDirectorAug 16 '23Sale97.5610,000975,6142,027,209Aug 18 07:01 PM
Hoge StephenPresidentAug 10 '23Sale102.5324725,3251,602,579Aug 11 04:18 PM
AFEYAN NOUBARDirectorAug 02 '23Sale110.9915,0001,664,8762,037,209Aug 04 07:00 PM
AFEYAN NOUBARDirectorJul 26 '23Sale120.4215,0001,806,2292,052,209Jul 28 07:05 PM
AFEYAN NOUBARDirectorJul 19 '23Sale125.4815,0001,882,1522,067,209Jul 21 07:00 PM
Hoge StephenPresidentJul 17 '23Sale120.6015,0001,809,0001,602,303Jul 18 04:35 PM